Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Extra Strength Postherpetic Neuralgia Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
April 28, 2017
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Gel
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
April 28, 2017
Manufacturer
ridge properties
Registration number
part348
NDC root
69804-059
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (4 NDCs)
Packaging & NDC Codes (4)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list to summarize. Without details about a particular medication, its uses, or how it works, I am unable to create a consumer-friendly summary. If you have specific information about a drug, please share it, and I would be happy to help!

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

If you have any questions or need further information about this medication, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

To ensure you use this medication correctly, it's important to follow the specific dosage and administration instructions provided. You should refer to the attached image for detailed guidance on how much to take and how often. This will include information on the route of administration, which means how the medication is delivered to your body, whether it's through a pill, injection, or another method.

Make sure to carefully review the instructions in the image to understand the proper method and frequency for taking or applying the medication. Following these guidelines will help you get the best results from your treatment. If you have any questions or need clarification, don’t hesitate to reach out to your healthcare provider.

What to Avoid

You can feel confident using this medication, as there are no specific contraindications (conditions that would prevent you from taking it) or concerns about abuse, misuse, or dependence (a condition where your body becomes reliant on a substance). Additionally, there are no particular instructions advising against its use. Always remember to follow your healthcare provider's guidance and reach out if you have any questions or concerns about your treatment.

Side Effects

You may not experience any specific side effects from this medication, as there are no notable adverse reactions listed. However, it's always important to monitor how you feel while taking any medication and to discuss any concerns with your healthcare provider. If you notice anything unusual, be sure to reach out for guidance.

Warnings and Precautions

It's important to be aware of certain precautions when using this medication. While specific warnings and general precautions are not detailed, you should always consult your healthcare provider about any concerns or questions you may have regarding your health and the use of this medication.

If you experience any unusual symptoms or side effects, it's crucial to stop taking the medication and call your doctor immediately. Additionally, if you feel that you are having a medical emergency, seek emergency help right away. Regular check-ups and lab tests may be necessary to monitor your health while on this medication, so be sure to follow your doctor's recommendations.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of this product during pregnancy has not been established. It is generally not recommended for use in pregnant women due to potential risks to the fetus. If you have any concerns or questions, you should consult your healthcare provider for personalized advice.

If your healthcare provider determines that you need to use this product, it should only be done after careful consideration and discussion. There are no specific dosage adjustments provided for pregnant patients, so following your provider's guidance is essential. Always prioritize your health and the health of your baby by seeking professional advice before using any medication during pregnancy.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

It's important to know that the safety and effectiveness of this product for children have not been established. This means that there hasn't been enough research to confirm whether it is safe or works well for kids. As a parent or caregiver, you should be cautious and consult with a healthcare professional before considering this product for your child.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and responses to medications, you should always consult with a healthcare provider before starting any new medication. They can help determine the right dosage and monitor for any potential side effects, ensuring that the treatment is safe and effective for you or your loved one.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted based on how well your kidneys are functioning. Regular monitoring of your kidney function tests is essential to ensure your safety and the effectiveness of your treatment.

If your creatinine clearance (a measure of kidney function) is less than 30 mL/min, a reduced dose of your medication is recommended. Additionally, if you have severe renal impairment, special care should be taken to avoid potential toxicity from the medication. Always consult with your healthcare provider to ensure your treatment plan is appropriate for your condition.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help monitor your liver function and determine the best approach for your treatment.

Make sure to keep your doctor informed about your liver health, as they may need to conduct regular liver function tests (which check how well your liver is working) to ensure your safety while using any medication.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best performance of your product, store it at room temperature, ideally between 20°C to 25°C (68°F to 77°F). It's important to keep the container tightly closed and protect it from light to maintain its effectiveness. Once you open the container, please remember to discard it after use to ensure safety and prevent contamination. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I do for dosage and administration instructions?

Refer to the attached image for detailed dosage and administration instructions.

Are there any contraindications for this product?

No specific contraindications are listed in the provided text.

Is this product safe to use during pregnancy?

Safety during pregnancy has not been established, and it is not recommended for use in pregnant women due to potential risks.

What precautions should pregnant women take?

Pregnant women should use this product only if clearly needed and after discussing with a healthcare professional.

Is there any information about nursing mothers?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

What should I know about using this product if I have renal impairment?

Patients with renal impairment may require dosage adjustments, and a reduced dose is recommended for those with a creatinine clearance of less than 30 mL/min.

How should I store this product?

Store at room temperature, 20°C to 25°C (68°F to 77°F), protect from light, and keep the container tightly closed.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Postherpetic Neuralgia Relief (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Postherpetic Neuralgia Relief.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Postherpetic Neuralgia Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The drug is presented in a package label featuring a principal display panel. The effective date of the insert is May 1, 2017. Additionally, the package label includes a referenced image of the product, identified as 2 oz.jpg.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider this information when evaluating treatment options for their patients.

Dosage and Administration

Healthcare professionals should refer to the attached image for detailed dosage and administration instructions, including specific dosing ranges and intervals.

The route of administration, method of delivery, and frequency of administration are also outlined in the attached image. It is essential to adhere to these guidelines to ensure optimal therapeutic outcomes and patient safety.

Contraindications

There are no contraindications listed for the use of this product. It is important to evaluate each patient's individual circumstances and medical history when considering treatment options.

Warnings and Precautions

Healthcare professionals should be aware of the critical importance of monitoring and managing patient safety when prescribing this medication.

In the absence of specific warnings, it is essential to remain vigilant for any adverse reactions that may arise during treatment. Healthcare providers are encouraged to maintain open lines of communication with patients regarding any unusual symptoms or side effects that may occur.

General precautions should be taken to ensure that patients are adequately informed about the potential risks associated with the medication. This includes advising patients to report any significant changes in their health status promptly.

Regular laboratory tests may be necessary to monitor the patient's response to the medication and to detect any potential complications early. Healthcare professionals should determine the appropriate tests based on the individual patient's health profile and the specific medication being prescribed.

In the event of a medical emergency, it is crucial for patients to seek immediate medical assistance. Healthcare providers should educate patients on recognizing signs that warrant urgent care.

If a patient experiences any concerning symptoms or side effects, they should be instructed to discontinue use of the medication and contact their healthcare provider without delay. This proactive approach can help mitigate risks and ensure patient safety throughout the course of treatment.

Side Effects

There are no specific adverse reactions or side effects listed in the provided data. As such, no further details regarding serious or common adverse reactions, clinical trial insights, or postmarketing experiences can be elaborated upon. It is important for healthcare professionals to monitor patients for any unexpected reactions and report them as necessary.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Postherpetic Neuralgia Relief (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Postherpetic Neuralgia Relief.
Details

Pediatric Use

Pediatric use has not been established for this product. Safety and effectiveness in pediatric patients have not been determined.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this product. Use is not recommended in pregnant women due to potential risks to the fetus. There may be risks associated with fetal outcomes; therefore, it is essential for pregnant patients to consult a healthcare provider for personalized advice. No specific dosage modifications are provided for pregnant patients. Pregnant women should use this product only if clearly needed and after thorough discussion with a healthcare professional regarding the potential benefits and risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may require dosage adjustments based on their level of kidney function. It is essential to monitor renal function tests regularly in patients with existing kidney problems. A reduced dose is recommended for patients with a creatinine clearance of less than 30 mL/min. Special consideration should be given to patients with severe renal impairment to avoid potential toxicity.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, specifically within the range of 20°C to 25°C (68°F to 77°F). It is essential to protect the product from light exposure to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Extra Strength Postherpetic Neuralgia Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Postherpetic Neuralgia Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.